Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria I, Longo"'
Publikováno v:
JAAD Case Reports, Vol 15, Iss , Pp 19-21 (2021)
Externí odkaz:
https://doaj.org/article/d41afe6f3ab34cb9894559a397486e57
Autor:
Margaret Ann, Kreher, Mary Margaret B, Noland, Sailesh, Konda, Maria I, Longo, Rodrigo, Valdes-Rodriguez
Publikováno v:
Journal of the American Academy of Dermatology. 88:521-530
Immunosuppression is a well-documented risk factor for skin cancer, as exemplified by the 65- to 250-fold higher squamous cell carcinoma risk, 10-fold higher basal cell carcinoma risk, and 0 to 8-fold higher melanoma risk in solid organ transplant re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d31b323a047194e8d96d56ea0c34d24
https://doi.org/10.1016/j.jaad.2022.11.044
https://doi.org/10.1016/j.jaad.2022.11.044
Autor:
Margaret Ann Kreher, Sailesh Konda, Mary Margaret B. Noland, Maria I. Longo, Rodrigo Valdes-Rodriguez
Publikováno v:
Journal of the American Academy of Dermatology.
In solid organ transplant recipients, skin cancer risk associated with post-transplant immunosuppression has been well-described, and screening practices generally reflect these risks. In addition to agents used post-transplant, other classes of immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3875a79cb27c5be6da16b5119fd56372
https://pubmed.ncbi.nlm.nih.gov/36460256
https://pubmed.ncbi.nlm.nih.gov/36460256
Publikováno v:
Dermatology online journal. 27(3)
Reactive angioendotheliomatosis (RAE) is an uncommon, benign, antiproliferative condition associated with systemic diseases that may cause occlusion or inflammation of the vascular lumina. A link between antiphospholipid syndrome (APS) and RAE has be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a22d829af8d01df4e0902cd2e063faa
https://pubmed.ncbi.nlm.nih.gov/33865281
https://pubmed.ncbi.nlm.nih.gov/33865281
Autor:
Magdalena B. Wozniak, Raquel Villuendas, James R. Bischoff, Carmen Blanco Aparicio, Juan F. Martínez Leal, Paloma de La Cueva, Ma Elena Rodriguez, Beatriz Herreros, Daniel Martin-Perez, Maria I. Longo, Marta Herrera, Miguel Á. Piris, Pablo L Ortiz-Romero
Publikováno v:
Haematologica, Vol 95, Iss 4 (2010)
Background Vorinostat (suberoylanilide hydroxamic acid, SAHA), an inhibitor of class I and II histone deacetylases, has been approved for the treatment of cutaneous T-cell lymphoma. In spite of emerging information on the effect of vorinostat in many
Externí odkaz:
https://doaj.org/article/28eee7d249f24154a5771a35c9a3f794